Immediately after this discovery inactivating TP53 mutations were confirmed to be a common event in the colorectal cancer tumorigenesis (17), and mutations occurring within this tumor suppressor were detected as a distinctive feature of Li-Fraumeni syndrome (18). This evidence concerns the gene TP53 and neoplasm.